David Nanchen

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


160 publications

In press | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
In press
 
Safety of beta-blocker discontinuation after acute coronary syndromes with preserved or mildly reduced left ventricular ejection fraction: a target trial emulation from a real-world cohort.
Johner N., Branca M., Carballo D., Baggio S., Nanchen D., Tessitore E., Räber L., Lüscher T.F., Matter C.M., Windecker S. et al. European journal of preventive cardiology. Peer-reviewed.
[DOI][Pmid][serval:BIB_B6769C08C189]
2024
Eligibility for marine omega-3 fatty acid supplementation after acute coronary syndromes.
Follonier C., Rabassa G., Branca M., Carballo D., Koskinas K., Heg D., Nanchen D., Räber L., Klingenberg R., Haller M.L. et al., 2024/12. Atherosclerosis plus, 58 pp. 1-8. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3D42335788BB]
Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study.
Ray K.K., Aguiar C., Arca M., Connolly D.L., Eriksson M., Ferrières J., Laufs U., Mostaza J.M., Nanchen D., Bardet A. et al., 2024/11/11. European journal of preventive cardiology, 31 (15) pp. 1792-1803. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_2DE5249F1EBE]
Association Between Patient Sex and Familial Hypercholesterolemia and Long-Term Cardiovascular Risk Factor Management 5 Years After Acute Coronary Syndrome.
Krasieva K., Gencer B., Locatelli I., Carballo D., Muller O., Fournier S., Matter C.M., Räber L., Rodondi N., Mach F. et al., 2024/08. Circulation. Cardiovascular quality and outcomes, 17 (8) pp. e010790. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_32B0D5479156]
Prévenir plutôt que traiter: comment le vélo et la marche peuvent réduire les coûts de la santé -Le Temps
Ohl Fabien, D'acremont Valérie, Kayser Bengt, Nanchen David, Rerat Patrick, 2024/06/04..
[URN][serval:BIB_646B4AC75D4C]
Drinking patterns of alcohol and risk of major adverse cardiovascular events after an acute coronary syndrome.
Tessitore E., Branca M., Heg D., Nanchen D., Auer R., Räber L., Klingenberg R., Windecker S., Lüscher T.F., Carballo S. et al., 2024/05/11. European journal of preventive cardiology, 31 (7) pp. 845-855. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AEB6B2CEB3BE]
 
Dépistage et prévention cardiovasculaire mobile dans la population : utile en Suisse ? [Mobile cardiovascular screening and prevention in the population : useful in Switzerland?]
Tarteret P., Campbell DJT, Vassaux S., Prior J., Darioli R., Nanchen D., 2024/03/06. Revue medicale suisse, 20 (864) pp. 466-471. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_1CB1A1438BFD]
 
Identifier et accompagner les patient-es sédentaires : un guide pratique [Identifying and assisting sedentary patients: a practical guide]
Thiébaud L., Nanchen D., Bize R., Baggish A., Saubade M., 2024/03/06. Revue medicale suisse, 20 (864) pp. 488-495. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B4649FDC1A16]
 
Le cholestérol dans l’enfance : est-il utile de le dépister ?
Nanchen D., Rodondi N., 2024/03/06. Revue medicale suisse, 20 (864) pp. 463-464. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_0A373491D639]
 
Modifications épigénétiques et maladies cardiovasculaires : nouvel Eldorado [Epigenetic modifications and cardiovascular diseases : new Eldorado]
Emery O., Nanchen D., Chamberlain J., 2024/03/06. Revue medicale suisse, 20 (864) pp. 496-499. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_8EB44AD462C3]
 
Évaluation du risque cardiovasculaire à l’aide du score calcique coronarien [Cardiovascular risk evaluation using the coronary artery calcium score]
Krasieva K., Tzimas G., Nanchen D., 2024/03/06. Revue medicale suisse, 20 (864) pp. 500-504. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_3013AB30683B]
 
Higher 1-year mortality on rest days in patients with acute coronary syndromes and decompensated heart failure-A SPUM-ACS sub-study.
Matter M.A., Candreva A., Stähli B.E., Heg D., Klingenberg R., Räber L., Windecker S., Rodondi N., Nanchen D., Mach F. et al., 2024/02. Catheterization and cardiovascular interventions, 103 (2) pp. 286-294. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A31E374A1EB0]
 
Anatomy-Informed Multimodal Learning for Myocardial Infarction Prediction.
Sievering I.D., Senouf O., Mahendiran T., Nanchen D., Fournier S., Muller O., Frossard P., Abbe E., Thanou D., 2024. IEEE open journal of engineering in medicine and biology, 5 pp. 837-845. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3CD05767B091]
2023
Comparison of the European and US guidelines for lipid-lowering therapy in primary prevention of cardiovascular disease.
Delabays B., de La Harpe R., Vollenweider P., Fournier S., Müller O., Strambo D., Graham I., Visseren FLJ, Nanchen D., Marques-Vidal P. et al., 2023/11/30. European journal of preventive cardiology, 30 (17) pp. 1856-1864. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_6CF92A071F8A]
History of peripheral artery disease and cardiovascular risk of real-world patients with acute coronary syndrome: Role of inflammation and comorbidities.
Denegri A., Magnani G., Kraler S., Bruno F., Klingenberg R., Mach F., Gencer B., Räber L., Rodondi N., Rossi V.A. et al., 2023/07/01. International journal of cardiology, 382 pp. 76-82. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_009B4EEC350F]
Low-density lipoprotein electronegativity and risk of death after acute coronary syndromes: A case-cohort analysis.
Kraler S., Wenzl F.A., Vykoukal J., Fahrmann J.F., Shen M.Y., Chen D.Y., Chang K.C., Chang C.K., von Eckardstein A., Räber L. et al., 2023/07. Atherosclerosis, 376 pp. 43-52. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4844F5CEC093]
 
Clinical outcomes in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary interventions later than 48 h after symptom onset.
Rohla M., Temperli F., Siontis GCM, Klingenberg R., Gencer B., Rodondi N., Bär S., Nanchen D., Mach F., Häner J.D. et al., 2023/06/02. European heart journal. Acute cardiovascular care, 12 (6) pp. 376-385. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_55EDA15F5F2B]
Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study.
Ray K.K., Haq I., Bilitou A., Manu M.C., Burden A., Aguiar C., Arca M., Connolly D.L., Eriksson M., Ferrières J. et al., 2023/06. The Lancet regional health. Europe, 29 p. 100624. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_93904463248E]
Smoking Cessation in People With and Without Diabetes After Acute Coronary Syndrome.
Clement L., Gencer B., Muller O., Klingenberg R., Räber L., Matter C.M., Lüscher T.F., Windecker S., Mach F., Rodondi N. et al., 2023/01/01. Nicotine & tobacco research, 25 (1) pp. 58-65. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_59B2E8AF9F0C]
Une histoire familiale d’hypercholestérolémie – le rôle de la génétique [A Family History of Hypercholesterolemia - the Role of Genetics]
Podmore C., Deillon E., Nanchen D., 2023. Praxis, 112 (4) pp. 245-249. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_5F507B465100]
2022
Nicotine Replacement Therapy for Smokers with Acute Aneurysmal Subarachnoid Hemorrhage: An International Survey.
Eisenring C.V., Hamilton P.L., Herzog P., Oertel M.F., Jacot-Sadowski I., Burn F., Cornuz J., Schatlo B., Nanchen D., 2022/11. Advances in therapy, 39 (11) pp. 5244-5258. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_65D8524DE1E9]
Smoking cessation and depression after acute coronary syndrome.
Krasieva K., Clair C., Gencer B., Carballo D., Klingenberg R., Räber L., Windecker S., Rodondi N., Matter C.M., Lüscher T.F. et al., 2022/10. Preventive medicine, 163 p. 107177. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3BD6922405D8]
Cohort Profile: The Lausanne cohort 65+ (Lc65+).
Henchoz Y., Blanco J.M., Fustinoni S., Nanchen D., Büla C., Seematter-Bagnoud L., von Gunten A., Santos-Eggimann B., 2022/08/10. International journal of epidemiology, 51 (4) pp. e156-e166. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0644DEB3FC47]
Long-term effects of systematic smoking cessation counselling during acute coronary syndrome, a multicentre before-after study.
Gilgien-Dénéréaz L., Jakob J., Tal K., Gencer B., Carballo D., Räber L., Klingenberg R., Matter C.M., Sudano I., Lüscher T.F. et al., 2022/07/18. Swiss medical weekly, 152 pp. w30209. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_9AF926FFECEB]
Dépistage génétique en cascade de l’hypercholestérolémie familiale - Une nouvelle opportunité pour la prévention cardiovasculaire [Cascade genetic testing of familial hypercholesterolemia A new opportunity for prevention]
Butty A., Von Känel T., Gallino A., Beer J.H., Nanchen D., 2022/03/09. Revue medicale suisse, 18 (772) pp. 438-443. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_539A27F7EE4E]
Oméga-3 fortement dosés pour la prévention cardiovasculaire : une fausse bonne idée ? [High-dose Omega-3 for cardiovascular prevention, a bad idea?]
Berger Christine, Gencer Baris, Nanchen David, 2022/03/09. Revue medicale suisse, 18 (772) pp. 434-437. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_7636797E2875]
Polypharmacie chez les patients âgés : peut-on arrêter certains médicaments ?
Rodondi N., 2022/03/09. Revue medicale suisse, 18 (772) pp. 407-408. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_889668B0033F]
Recommandations européennes 2021 pour la prévention cardiovasculaire : nouveautés [European guidelines 2021 for the cardiovascular prevention: new concepts]
Vasilakou E., Carballo D., Nanchen D., 2022/03/09. Revue medicale suisse, 18 (772) pp. 410-413. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_313DFA15D7AD]
Genetic cascade screening for familial hypercholesterolemia in Switzerland
Nanchen David, Beer Jurg Hans, Gallino Augusto, 2022/03/01. Cardiovascular Medicine. Peer-reviewed.
[URN][DOI][serval:BIB_9B10B913C2BA]
 
Effectiveness, Adherence, and Safety of Evolocumab in a Swiss Multicenter Prospective Observational Study.
Nanchen D., Carballo D., Bilz S., Rickli H., Koskinas K.C., Mach F., Mueller C., Crljenica C., Rossi M., Reichert N. et al., 2022/01. Advances in therapy, 39 (1) pp. 504-517. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BA8EC7971B3B]
Von Kräutern zu Pillen, Biologics und Nukleinsäuren: Das Lipid-Management der Zukunft [The lipid management of the future: From herbs to pills, biologics and nucleic acids]
Lüscher Thomas F., von Eckardstein Arnold, Beer Jürg Hans, Räber Lorenz, Sudano Isabella, Nanchen David, Mueller Christian, Mach François, Landmesser Ul, 2022. Cardiovascular Medicine, 25 (1) pp. 3-11. Peer-reviewed.
[URN][DOI][serval:BIB_FC45B38001F5]
2021
Association between self-reported motivation to quit smoking with effectiveness of smoking cessation intervention among patients hospitalized for acute coronary syndromes in Switzerland.
Worni-Schudel I., Tzalis V., Jakob J., Tal K., Gilgien-Dénéréaz L., Gencer B., Matter C.M., Lüscher T.F., Windecker S., Mach F. et al., 2021/12. Preventive medicine reports, 24 p. 101583. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_FC27EEC60833]
Conseils pour une alimentation saine : perspectives cliniques et communautaires [Healthy eating counseling : Clinical and community perspectives]
Nanchen D., Crisinel Favre C., Bochud M., 2021/11/10. Revue medicale suisse, 17 (758) pp. 1927-1931. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_EDDC95DDCD1E]
Trois approches de communication médecin-patient et prévention : quel modèle pour quelle situation ? [Three approaches to doctor-patient communication and prevention : Which model for which situation ?]
Habfast-Robertson I., Hempel-Bruder C., Durand M.A., Morin D., Remillard S., Nanchen D., Daeppen J.B., Berlin I., Selby K., 2021/11/10. Revue medicale suisse, 17 (758) pp. 1934-1938. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_48DBCFCC33EA]
 
Improving 1-year mortality prediction in ACS patients using machine learning.
Weichwald S., Candreva A., Burkholz R., Klingenberg R., Räber L., Heg D., Manka R., Gencer B., Mach F., Nanchen D. et al., 2021/10/27. European heart journal. Acute cardiovascular care, 10 (8) pp. 855-865. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6CD3CDCD389B]
Cysteine-Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary Syndromes.
Klingenberg R., Aghlmandi S., Räber L., Akhmedov A., Gencer B., Carballo D., Nanchen D., Bucher H.C., Rodondi N., Mach F. et al., 2021/10/19. Journal of the American Heart Association, 10 (20) pp. e020488. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D4792254A9AD]
CCN family member 1 (CCN1) is an early marker of infarct size and left ventricular dysfunction in STEMI patients.
Mahendiran T., Klingenberg R., Nanchen D., Gencer B., Meier D., Räber L., Carballo D., Matter C.M., Lüscher T.F., Mach F. et al., 2021/10. Atherosclerosis, 335 pp. 77-83. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3343771B7BD5]
Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe - Methodology and rationale for the multinational observational SANTORINI study.
Ray K.K., Haq I., Bilitou A., Aguiar C., Arca M., Connolly D.L., Eriksson M., Ferrières J., Hildebrandt P., Laufs U. et al., 2021/09. Atherosclerosis plus, 43 pp. 24-30. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6546628A5894]
 
Implementation of cascade genetic screening for familial hypercholesterolemia: Design of the Swiss catch randomized controlled trial
Nanchen D., Von Känel T., Brun N., Sudano I., Rickli H., Ehret G., Girod G., Del Giorno R., Rodondi N., Beer J.H. et al., 2021/08. pp. e184 dans EAS 2021 abstracts : European Atherosclerosis Society, Atherosclerosis.
[DOI][WoS][serval:BIB_9EE9DF76C8BC]
 
Prognostic value of inflammatory biomarkers and GRACE score for cardiac death and acute kidney injury after acute coronary syndromes.
Rossi V.A., Denegri A., Candreva A., Klingenberg R., Obeid S., Räber L., Gencer B., Mach F., Nanchen D., Rodondi N. et al., 2021/05/25. European heart journal. Acute cardiovascular care, 10 (4) pp. 445-452. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EF7A3470DB72]
 
Comparison of Swiss and European risk algorithms for cardiovascular prevention in Switzerland.
Beuret H., Hausler N., Nanchen D., Méan M., Marques-Vidal P., Vaucher J., 2021/04/10. European journal of preventive cardiology, 28 (2) pp. 204–210. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_97FFA54D91E0]
 
Prognostic value of total testosterone levels in patients with acute coronary syndromes.
Gencer B., Vuilleumier N., Nanchen D., Collet T.H., Klingenberg R., Räber L., Auer R., Carballo D., Carballo S., Aghlmandi S. et al., 2021/04/10. European journal of preventive cardiology, 28 (2) pp. 235–242. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_75744D24CEA2]
 
Impact of malignancy on clinical outcomes in patients with acute coronary syndromes.
Yousif N., Niederseer D., Davies A., El Issa M., Sidia B., Noor H.A., Amin H., Räber L., Gencer B., Klingenberg R. et al., 2021/04/01. International journal of cardiology, 328 pp. 8-13. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_389ED28FEDA2]
Novel Blood Biomarkers for a Diagnostic Workup of Acute Aortic Dissection.
Forrer A., Schoenrath F., Torzewski M., Schmid J., Franke UFW, Göbel N., Aujesky D., Matter C.M., Lüscher T.F., Mach F. et al., 2021/03/30. Diagnostics, 11 (4) p. 615. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_222B8B157415]
Eligibility for PCSK9 inhibitors based on the 2019 ESC/EAS and 2018 ACC/AHA guidelines.
Koskinas K.C., Gencer B., Nanchen D., Branca M., Carballo D., Klingenberg R., Blum M.R., Carballo S., Muller O., Matter C.M. et al., 2021/03/23. European journal of preventive cardiology, 28 (1) pp. 59-65. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_93EA67EF9F1C]
Document de consensus sur la prise en charge du cholestérol LDL
Mach François, Gallino Augusto, Haegeli Laurent M., Kobza Richard, Koskinas Konstantinos, Miserez André, Nanchen David, Pedrazzini Giovanni, Räber Lorenz, Sudano Isabella et al., 2021/03/10. Cardiovascular Medicine, 24 (2).
[URN][DOI][serval:BIB_6F45ADCA7D9D]
Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse events.
Klingenberg R., Aghlmandi S., Gencer B., Nanchen D., Räber L., Carballo D., Carballo S., Stähli B.E., Landmesser U., Rodondi N. et al., 2021/03. Atherosclerosis, 320 pp. 31-37. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_541186F9F92C]
 
Impact of smoking cessation on depression after acute coronary syndrome
Krasieva K., Clair Carole, Gencer B., Carballo D., Klingenberg R., Raber L., Windecker S., Rodondi N., Matter C. M., Luscher T. F. et al., 2021. p. 2598 dans ESC Congress 2021 – The Digital Experience, 27–30 August 2021, European Heart Journal.
[DOI][serval:BIB_C4FFD50AD89A]
 
Older People's Health-Related Behaviors: Evidence from Three Cohorts of the Lc65+ Study.
Seematter-Bagnoud L., Santos-Eggimann B., Nanchen D., Blanco J.M., Büla C., von Gunten A., Démonet J.F., Henchoz Y., 2021. Behavioral medicine, 47 (3) pp. 246-250. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9AB81BD9523F]
 
Systemic immune-inflammation index predicts major adverse cardiovascular events in patients with ST-elevation myocardial infarction
Denegri Andrea, Obeid Slayman, Raeber Lorenz, Windecker S., Gencer Baris, Mach F., Rodondi N., Heg Dik, Nanchen David, Matter C. M. et al., 2021. p. 1353 dans ESC Congress 2021 – The Digital Experience 27–30 August 2021, European Heart Journal .
[DOI][serval:BIB_544F9AD1BF3E]
2020
 
Prognostic role of plasma galectin-3 levels in acute coronary syndrome.
Obeid S., Yousif N., Davies A., Loretz R., Saleh L., Niederseer D., Noor H.A., Amin H., Mach F., Gencer B. et al., 2020/12. European heart journal. Acute cardiovascular care, 9 (8) pp. 869-878. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B1D69A369B2C]
Trends in Physical and Cognitive Performance Among Community-Dwelling Older Adults in Switzerland.
Henchoz Y., Büla C., von Gunten A., Blanco J.M., Seematter-Bagnoud L., Démonet J.F., Waeber G., Nanchen D., Santos-Eggimann B., 2020/11/13. The journals of gerontology. Series A, Biological sciences and medical sciences, 75 (12) pp. 2347-2353. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6197FED36533]
 
Residual inflammatory risk at 12 months after acute coronary syndromes is associated with cardiovascular outcome
Klingenberg R, Aghlmandi S, Nanchen D, Raeber L, Gencer B, Carballo D, Carballo S, Landmesser U, Rodondi N, Mach F et al., 2020/11/01. dans European Heart Journal, European Heart Journal, Oxford University Press (OUP).
[DOI][serval:BIB_02DCEAA742C9]
 
Prognostic values of fasting hyperglycaemia in non-diabetic patients with acute coronary syndrome: A prospective cohort study.
Gencer B., Rigamonti F., Nanchen D., Klingenberg R., Räber L., Moutzouri E., Auer R., Carballo D., Heg D., Windecker S. et al., 2020/09. European heart journal. Acute cardiovascular care, 9 (6) pp. 589-598. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8053F0321FE0]
 
Prognosis of Patients with Chronic and Hospital-Acquired Anaemia After Acute Coronary Syndromes.
Mahendiran T., Nanchen D., Gencer B., Meier D., Klingenberg R., Räber L., Carballo D., Matter C.M., Lüscher T.F., Windecker S. et al., 2020/08. Journal of cardiovascular translational research, 13 (4) pp. 618-628. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_340120A399E3]
[Conseil en activité physique] : Réponse
Spring J.N., Bize R., Saubade M., Nanchen D., 2020/06/10. Revue medicale suisse, 16 (697) p. 1216.
[URN][DOI][Pmid][serval:BIB_A56954E0CD9D]
Modernes Lipid-Management
Lüscher Thomas F., Gallino Augusto, Haegeli Laurent M., Kobza Richard, Koskinas Konstantinos, Miserez Andr, Nanchen David, Noll Georg, Pedrazzini Giovanni, Räber Lorenz et al., 2020/03/31. Cardiovascular Medicine, 23 pp. w02102. Peer-reviewed.
[URN][DOI][serval:BIB_ADE30260434E]
 
Intensified lipid lowering using ezetimibe after publication of the IMPROVE-IT trial: A contemporary analysis from the SPUM-ACS cohort.
Gencer B., Carballo D., Nanchen D., Koskinas K.C., Klingenberg R., Räber L., Auer R., Carballo S., Heg D., Windecker S. et al., 2020/03/15. International journal of cardiology, 303 pp. 8-13. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6FD93ED5EC69]
Aspirine en prévention cardiovasculaire primaire : la fin d’une époque ? [Aspirin for primary cardiovascular prevention : the end of an era ?]
Ravach G., Fournier S., Mazzolai L., Nanchen D., 2020/03/04. Revue medicale suisse, 16 (684) pp. 459-462. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_7A4F74482DF5]
 
Conseil en activité physique - Sa délégation vers une spécialiste en activité physique adaptée : le projet Pas à Pas [Physical activity counseling Referring to an adapted physical activity specialist : example of the Step by Step+ project]
Spring J.N., Saubade M., Bize R., Pasche M., Nanchen D., 2020/03/04. Revue medicale suisse, 16 (684) pp. 444-447. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_127443BE0722]
Controverses sur le dépistage et la prise en charge des dyslipidémies familiales en 2020 [Controversies concerning screening and treatment of primary dyslipidemias in 2020]
Bretagne L., Aubert C., Nanchen D., Rodondi N., 2020/03/04. Revue medicale suisse, 16 (684) pp. 433-437. Peer-reviewed.
[URN][Pmid][serval:BIB_24A64741D9AA]
Faut-il parler du style de vie à chaque patient ? [Should the lifestyle be discussed with every patient?]
Nanchen D., Rodondi N., 2020/03/04. Revue medicale suisse, 16 (684) p. 431. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_E57A1CEEF5BF]
Nouvelles recommandations européennes et américaines pour les dyslipidémies : similitudes et différences [New European and American guidelines on the management of blood cholesterol : similarities and differences]
Butty A., Rodondi N., Nanchen D., 2020/03/04. Revue medicale suisse, 16 (684) pp. 438-443. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_1E564A425519]
 
Control of cardiovascular risk factors and health behaviors in patients post acute coronary syndromes eligible for protein convertase subtilisin/kexin-9 inhibitors.
Butty A., Gencer B., Koskinas K.C., Carballo D., Räber L., Klingenberg R., Matter C.M., Lüscher T.F., Windecker S., Muller O. et al., 2020/01/15. International journal of cardiology, 299 pp. 289-295. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E32FC1F9E616]
Optimal Timing of Invasive Coronary Angiography following NSTEMI.
Mahendiran T., Nanchen D., Meier D., Gencer B., Klingenberg R., Räber L., Carballo D., Matter C.M., Lüscher T.F., Windecker S. et al., 2020. Journal of interventional cardiology, 2020 p. 8513257. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_077F882FB39B]
 
Uncontrolled hypertension and elevated NT-proBNP predict acute kidney injury and cardiac death in all-comer patients 1 year after acute coronary syndromes
Denegri A., Raeber L., Windecker S., Gencer B., Mach F., Rodondi N., Heg D., Nanchen D., Klingenberg R., Matter C. M. et al., 2020. p. 1655 dans ESC Congress 2020 – The Digital Experience 29 August – 1 September 2020, European Heart Journal.
[DOI][serval:BIB_C433DEB65EAD]
2019
Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61.
Winzap P., Davies A., Klingenberg R., Obeid S., Roffi M., Mach F., Räber L., Windecker S., Templin C., Nietlispach F. et al., 2019/10/31. Cardiovascular diabetology, 18 (1) p. 142. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BC6FED59C661]
 
Vers un universalisme proportionné en promotion de la santé et prévention : réflexions et pistes d’action [Towards proportionate universalism in health promotion and prevention : reflections and courses of action]
Lutz A., Zuercher K., Nanchen D., Pasche M., 2019/10/30. Revue medicale suisse, 15 (669) pp. 1987-1990. Peer-reviewed.
[Pmid][serval:BIB_0CDE10E71903]
 
Intensification of lipid lowering therapy before and after publication of the IMPROVE-IT trial: A temporal analysis from the SPUM-ACS cohort
Gencer B., Carballo D., Nanchen D., Koskinas K., klingenberg R., Raeber L., Auer R., Carballo S., Heg D., Windecker S. et al., 2019/10. p. 678 dans European Heart Journal.
[WoS][serval:BIB_C3111BDDA8F2]
 
Trimethyllysine, a trimethylamine N-oxide precursor, provides near- and long-term prognostic value in patients presenting with acute coronary syndromes.
Li X.S., Obeid S., Wang Z., Hazen B.J., Li L., Wu Y., Hurd A.G., Gu X., Pratt A., Levison B.S. et al., 2019/08/21. European heart journal, 40 (32) pp. 2700-2709. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_115AA6847135]
 
Inflammation during acute coronary syndromes - Risk of cardiovascular events and bleeding.
Nanchen D., Klingenberg R., Gencer B., Räber L., Carballo D., von Eckardstein A., Windecker S., Rodondi N., Lüscher T.F., Mach F. et al., 2019/07/15. International journal of cardiology, 287 pp. 13-18. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9699DC499E74]
Non-Linear Relationship between Anti-Apolipoprotein A-1 IgGs and Cardiovascular Outcomes in Patients with Acute Coronary Syndromes.
Vuilleumier N., Pagano S., Combescure C., Gencer B., Virzi J., Räber L., Carballo D., Carballo S., Nanchen D., Rodondi N. et al., 2019/07/09. Journal of clinical medicine, 8 (7). Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_ABC2785E2CEB]
 
Une réalité à ne pas sous-estimer: Maladies cardiovasculaires ischémiques chez les femmes
Simon Eszter, Bouchardy Judith, Nanchen David, Clair Carole, 2019/07/04. la gazette médicale, 8 (4) pp. 13-16.
[serval:BIB_AA3272E8211D]
 
Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromes.
Gencer B., Rigamonti F., Nanchen D., Vuilleumier N., Kern I., Aghlmandi S., Klingenberg R., Räber L., Auer R., Carballo D. et al., 2019/07. European journal of clinical investigation, 49 (7) pp. e13117. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_32BF5E07E54C]
Association between income and control of cardiovascular risk factors after acute coronary syndromes: an observational study.
Jaquet E., Gencer B., Auer R., Moschetti K., Muller O., Matter C.M., Lüscher T.F., Mach F., Rodondi N., Bodenmann P. et al., 2019/04/08. Swiss medical weekly, 149 pp. w20049. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_53A822214A12]
Do baby boomers feel healthier than earlier cohorts after retirement age? The Lausanne cohort Lc65+ study.
Henchoz Y., von Gunten A., Büla C., Seematter-Bagnoud L., Nanchen D., Démonet J.F., Blanco J.M., Santos-Eggimann B., 2019/02/19. BMJ open, 9 (2) pp. e025175. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F5A039F801D7]
Childhood adversity: A gateway to multimorbidity in older age?
Henchoz Y., Seematter-Bagnoud L., Nanchen D., Büla C., von Gunten A., Démonet J.F., Santos-Eggimann B., 2019. Archives of gerontology and geriatrics, 80 pp. 31-37. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_923BD56F9AD2]
Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare intervention.
Carballo D., Rodondi N., Auer R., Carballo S., Nanchen D., Räber L., Klingenberg R., Keller P.F., Heg D., Jüni P. et al., 2019. PloS one, 14 (2) pp. e0211464. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_058658940BB2]
 
Gender and age differences in outcomes of patients with acute coronary syndromes referred for coronary angiography.
Stähli B.E., Wischnewsky M.B., Jakob P., Klingenberg R., Obeid S., Heg D., Räber L., Windecker S., Mach F., Gencer B. et al., 2019/01/01. Catheterization and cardiovascular interventions, 93 (1) pp. 16-24. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B166C03E65B4]
2018
 
Predictive value of the age, creatinine, and ejection fraction (ACEF) score in patients with acute coronary syndromes.
Stähli B.E., Wischnewsky M.B., Jakob P., Klingenberg R., Obeid S., Heg D., Räber L., Windecker S., Roffi M., Mach F. et al., 2018/11/01. International journal of cardiology, 270 pp. 7-13. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_266F50CE5A99]
 
Prognostic value of pulse pressure after an acute coronary syndrome.
Harbaoui B., Nanchen D., Lantelme P., Gencer B., Heg D., Klingenberg R., Räber L., Carballo D., Matter C.M., Windecker S. et al., 2018/10. Atherosclerosis, 277 pp. 219-226. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_109D84F77363]
 
Thrombus aspiration in acute coronary syndromes: prevalence, procedural success, change in serial troponin T levels and clinical outcomes in a contemporary Swiss cohort.
Aghlmandi S., Schärer N., Heg D., Räber L., Zwahlen M., Gencer B., Nanchen D., Carballo D., Carballo S., Jüni P. et al., 2018/09. European heart journal. Acute cardiovascular care, 7 (6) pp. 522-531. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_396E9E38241A]
 
Resting heart rate: what is normal?
Nanchen D., 2018/07. Heart, 104 (13) pp. 1048-1049. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_358A3949DA36]
 
Hypercholestérolémie familiale : identifier et traiter
Nanchen David, 2018/04. La gazette médicale, 7 (3) pp. 17-19. Peer-reviewed.
[DOI][serval:BIB_940CCE7D12E9]
 
Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score.
Klingenberg R., Aghlmandi S., Räber L., Gencer B., Nanchen D., Heg D., Carballo S., Rodondi N., Mach F., Windecker S. et al., 2018/03. European heart journal. Acute cardiovascular care, 7 (2) pp. 129-138. Peer-reviewed.
[DOI][Pmid][serval:BIB_E7E3720983DF]
 
Dépistage de l’athérosclérose pour prévenir le risque cardiovasculaire : un débat pro-contre [Screening for atherosclerosis to prevent cardiovascular risk : a pro-contra debate]
Nanchen D., Genest J., 2018/02/28. Revue medicale suisse, 14 (596) pp. 477-480. Peer-reviewed.
[Pmid][serval:BIB_AEA5015367CF]
 
Etat des connaissances en 2018 sur les anticorps anti-PCSK9 [Current update on PCKS9 inhibitors]
Gencer B., Nanchen D., Collet T.H., Rodondi N., Mach F., 2018/02/28. Revue medicale suisse, 14 (596) pp. 482-486. Peer-reviewed.
[Pmid][serval:BIB_E00ED676BFC5]
 
Stratégies de prévention cardiovasculaire au cabinet [Strategies for cardiovascular disease prevention]
Gabus V., Wuerzner G., Saubade M., Favre L., Jacot Sadowski I., Nanchen D., 2018/02/28. Revue medicale suisse, 14 (596) pp. 488-492. Peer-reviewed.
[Pmid][serval:BIB_ED942826EF78]
 
Surconsommation médicale et traitements hypolipémiants en 2018 []
Rodondi N., Nanchen D., 2018/02/28. Revue medicale suisse, 14 (596) pp. 451-452. Peer-reviewed.
[Pmid][serval:BIB_C085D1D2CDAA]
The Swiss army knife impact study: a survival analysis
Auer R., Bodenmann B., Clair C., Cohidon C., Deruaz Luyet A., de Vallière S., Ebert ST, Favrat B., Herzig L., Jacot Sadowski I. et al., 2018/02/21. Primary and hospital care, 18 (04) pp. 64-65. Peer-reviewed.
[URN][DOI][serval:BIB_097FC517D489]
Hypercholestérolémie familiale: optimiser le diagnostic et le traitement
Nanchen David, 2018/01/17. Cardiovascular Medicine, 21 (01) pp. 16-21.
[URN][DOI][serval:BIB_93F087C12389]
Prognosis of cardiovascular and non-cardiovascular multimorbidity after acute coronary syndrome.
Canivell S., Muller O., Gencer B., Heg D., Klingenberg R., Räber L., Carballo D., Matter C., Lüscher T., Windecker S. et al., 2018. PloS one, 13 (4) pp. e0195174. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_535BD91177FC]
2017
 
Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromes.
Klingenberg R., Aghlmandi S., Liebetrau C., Räber L., Gencer B., Nanchen D., Carballo D., Akhmedov A., Montecucco F., Zoller S. et al., 2017/12/14. European heart journal, 38 (47) pp. 3493-3502. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_14FB205C5795]
Traitement hypolipémiant en prévention secondaire : descendre sous les valeurs cibles ?
Nanchen D., 2017/12/13. Revue medicale suisse, 13 (587) pp. 2196-2197. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_1195EF1495CD]
Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary Syndromes.
Gencer B., Koskinas K.C., Räber L., Karagiannis A., Nanchen D., Auer R., Carballo D., Carballo S., Klingenberg R., Heg D. et al., 2017/11/09. Journal of the American Heart Association, 6 (11) pp. NA. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6ADD45556097]
 
Is atherosclerosis imaging the most sensitive way to assess patients' risk and the best way to conduct future drug trials? A pros-and-cons debate.
Nanchen D., Raggi P., 2017/11. Atherosclerosis, 266 pp. 229-233. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0DBDDBAB7ACD]
 
Association between income and control of cardiovascular risk factors after acute coronary syndrome
Moschetti K., Jaquet E, Bodenmann P., Cornuz J., Muller O., Nanchen D., 2017/08/01. dans ESC Congress 2017, 26-30 August, Barcelona, Spain, European Heart Journal.
[DOI][serval:BIB_A37C69006DEE]
 
Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
Li X.S., Obeid S., Klingenberg R., Gencer B., Mach F., Räber L., Windecker S., Rodondi N., Nanchen D., Muller O. et al., 2017/03/14. European heart journal, 38 (11) pp. 814-824. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E968A59CAD15]
 
Profiling and validation of circulating microRNAs for cardiovascular events in patients presenting with ST-segment elevation myocardial infarction.
Jakob P., Kacprowski T., Briand-Schumacher S., Heg D., Klingenberg R., Stähli B.E., Jaguszewski M., Rodondi N., Nanchen D., Räber L. et al., 2017/02/14. European heart journal, 38 (7) pp. 511-515. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FFF276F8CBB7]
Le style de vie permet de contrer un profil génétique défavorable
Nanchen D., 2017/01/18. Revue medicale suisse, 13 (546) p. 173. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_1A6C7E1AA474]
2016
 
Délégation médicale vers un(e) spécialiste en activité physique adaptée (APA) : un projet pilote [Exercise-referral to a specialist in adapted physical activity (APA) : a pilot project]
Brugnerotto A., Cardinaux R., Ueltschi Y., Bauwens M., Nanchen D., Cornuz J., Bize R., Auer R., 2016/11/02. Revue medicale suisse, 12 (537) pp. 1845-1850. Peer-reviewed.
[Pmid][serval:BIB_7FC8EEB2CAB5]
Uptake and efficacy of a systematic intensive smoking cessation intervention using motivational interviewing for smokers hospitalised for an acute coronary syndrome: a multicentre before-after study with parallel group comparisons.
Auer R., Gencer B., Tango R., Nanchen D., Matter C.M., Lüscher T.F., Windecker S., Mach F., Cornuz J., Humair J.P. et al., 2016/09/20. BMJ open, 6 (9) pp. e011520. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_37755939D56A]
 
Identifying familial hypercholesterolemia in acute coronary syndrome.
Gencer B., Nanchen D., 2016/08. Current opinion in lipidology, 27 (4) pp. 375-381. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_618C4626D68C]
Associations Between Cardiovascular Risk Factors, Inflammation, and Progression of Carotid Atherosclerosis Among Smokers.
Zingg S., Collet T.H., Locatelli I., Nanchen D., Depairon M., Bovet P., Cornuz J., Rodondi N., 2016/06. Nicotine & tobacco research, 18 (6) pp. 1533-1538. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AB535DCED286]
 
Adhésion aux statines: mise à jour et plan d'action [Adherence to statins: updates and practical proposals]
Bauwens M., Schneider M.P., Nanchen D., 2016/03/02. Revue medicale suisse, 12 (508) pp. 445-448, 450. Peer-reviewed.
[Pmid][serval:BIB_672A60F8DCDE]
 
Prognostic value of PCSK9 levels in patients with acute coronary syndromes.
Gencer B., Montecucco F., Nanchen D., Carbone F., Klingenberg R., Vuilleumier N., Aghlmandi S., Heg D., Räber L., Auer R. et al., 2016/02/07. European heart journal, 37 (6) pp. 546-553. Peer-reviewed.
[DOI][Pmid][serval:BIB_6842B885C6D9]
 
Délégation médicale vers un(e) spécialiste en activité physique adaptée (APA) : un projet pilote
Brugnerotto A., Cardinaux R., Ueltschi Y., Bauwens M., Nanchen D., Cornuz J., Bize R., Auer R., 2016. Revue Médicale Suisse, 12 (537) pp. 1845-1850.
[serval:BIB_4FB111E442DE]
 
Fréquence cardiaque de repos: quelle utilité pour la prévention cardiovasculaire [Resting heart rate: how to use it for cardiovascular prevention?].
Fassbind M., Yerly P., Nanchen D., 2016. Revue Medicale Suisse, 12 (508) pp. 454, 456-454, 459. Peer-reviewed.
[Pmid][serval:BIB_D8058A59B82C]
 
Health utility indexes in patients with acute coronary syndromes.
Gencer B., Rodondi N., Auer R., Nanchen D., Räber L., Klingenberg R., Pletscher M., Jüni P., Windecker S., Matter C.M. et al., 2016. Open Heart, 3 (1) pp. e000419. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_ACE092D8F42E]
Hospital revascularisation capability and quality of care after an acute coronary syndrome in Switzerland.
Welker J., Auer R., Gencer B., Muller O., Cornuz J., Matter C.M., Mach F., Windecker S., Rodondi N., Nanchen D., 2016. Swiss Medical Weekly, 146 pp. w14275. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_50B9CB9EAC3D]
Identification and molecular characterisation of Lausanne Institutional Biobank participants with familial hypercholesterolaemia - a proof-of-concept study.
Maurer F., Pradervand S., Guilleret I., Nanchen D., Maghraoui A., Chapatte L., Bojkowska K., Bhuiyan Z.A., Jacquemont N., Harshman K. et al., 2016. Swiss medical weekly, 146 pp. w14326. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_3496C46C20B6]
 
Nouvelles recommandations pour le dépistage et la prise en charge des dyslipidémies familiales [New guidelines for screening and management of familial dyslipidemia].
Brun N., Aubert C.E., Nanchen D., Rodondi N., 2016. Revue Medicale Suisse, 12 (508) pp. 435-439. Peer-reviewed.
[Pmid][serval:BIB_61E6330EC1D8]
 
Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary Syndromes.
Nanchen D., Gencer B., Muller O., Auer R., Aghlmandi S., Heg D., Klingenberg R., Räber L., Carballo D., Carballo S. et al., 2016. Circulation, 134 (10) pp. 698-709. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9A968E83434F]
2015
 
Expected impact of applying new 2013 AHA/ACC cholesterol guidelines criteria on the recommended lipid target achievement after acute coronary syndromes.
Gencer B., Auer R., Nanchen D., Räber L., Klingenberg R., Carballo D., Blum M., Vogt P., Carballo S., Meyer P. et al., 2015. Atherosclerosis, 239 (1) pp. 118-124. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CFBDAF32A0BE]
 
L'index glycémique est peu utile chez les non-diabétiques [The glycemic index is of little use in non-diabetics].
Nanchen D., 2015. Revue Médicale Suisse, 11 (461) p. 425.
[Pmid][serval:BIB_ACF9DD843572]
 
Low statin use in adults hospitalized with acute coronary syndrome.
Selby K., Nanchen D., Auer R., Gencer B., Räber L., Klingenberg R., Blum M., Marques-Vidal P., Cornuz J., Muller O. et al., 2015. Preventive Medicine, 77 pp. 131-136. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_06398E164B1C]
Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes.
Nanchen D., Gencer B., Auer R., Räber L., Stefanini G.G., Klingenberg R., Schmied C.M., Cornuz J., Muller O., Vogt P. et al., 2015. European Heart Journal, 36 (36) pp. 2438-2445. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F6BBBCACCC3A]
Prise en charge des facteurs de risque des maladies cardiovasculaires: qu'est-ce qui a vraiment changé en 15 ans [Management of cardiovascular diseases in adults from 1999 to 2014: what has really changed?].
Barthel C., Nanchen D., Jornayvaz F.R., Wuerzner G., Senn N., 2015. Revue Médicale Suisse, 11 (496) pp. 2228, 2230-2228, 2235. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_00C3BE9BD61E]
 
Reasons for discontinuation of recommended therapies according to the patients after acute coronary syndromes.
Gencer B., Rodondi N., Auer R., Räber L., Klingenberg R., Nanchen D., Carballo D., Vogt P., Carballo S., Meyer P. et al., 2015/01. European Journal of Internal Medicine, 26 (1) pp. 56-62. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4D7ED76266C8]
 
Safety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in Switzerland.
Klingenberg R., Heg D., Räber L., Carballo D., Nanchen D., Gencer B., Auer R., Jaguszewski M., Stähli B.E., Jakob P. et al., 2015. Heart, 101 (11) pp. 854-863. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7962F2D4E6C3]
 
Statines en prévention primaire: comment décider avec le patient [Statins in primary prevention: how to share the decision?].
Nanchen D., Vonnez J.L., Selby K., Auer R., Cornuz J., 2015. Revue Médicale Suisse, 11 (496) pp. 2222-2226. Peer-reviewed.
[Pmid][serval:BIB_A5FB41798903]
2014
 
Prise en charge du cholestérol pour prévenir le risque cardiovasculaire:recommandations américaines 2013.Prise de position du Groupe de travail Suisse Lipides et Athérosclérose (GSLA).
Nanchen D., von Eckardstein A., Riesen F.W., Beer H-J., Conen D., Carballo D., Darioli R., James R., Mach F., Mordasini R. et al., 2014/05. Forum médical suisse, 14 (19) pp. 378-381.
[serval:BIB_E514240039A2]
 
Comment diminuer son risque cardiovasculaire avec l'alimentation? Rôle des graisses consommées [Nutritional advice to help reduce the cardiovascular risk. Update of the Swiss Federal Office of Public Health's recommendations on fat consumption].
Le Boudec J., Pedrazzini B., Andrey M., Ruiz J., Cornuz J., Nanchen D., 2014/03. Revue Médicale Suisse, 10 (420) pp. 532-4, 536-8.
[Pmid][serval:BIB_E7EABE37EF0B]
Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
Kavousi M., Leening M.J., Nanchen D., Greenland P., Graham I.M., Steyerberg E.W., Ikram M.A., Stricker B.H., Hofman A., Franco O.H., 2014. Jama, 311 (14) pp. 1416-1423. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_39F6D3A57A1E]
Prévention primaire et dépistage chez l'adulte: mise a jour 2014 [Primary prevention and screening in adults: update 2014].
Cornuz J., Jacot-Sadowski I., Nanchen D., Auer R., Senn N., Lazor R., Guessous I., 2014. Revue Médicale Suisse, 10 (414) pp. 177-8, 180-5. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_3CC0C3AF902D]
Quality of care after acute coronary syndromes in a prospective cohort with reasons for non-prescription of recommended medications.
Auer R., Gencer B., Räber L., Klingenberg R., Carballo S., Carballo D., Nanchen D., Cornuz J., Vader J.P., Vogt P. et al., 2014. Plos One, 9 (3) pp. e93147. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_196A04D0B560]
2013
 
Acquisitions thérapeutiques en médecine ambulatoire en 2012. [2012 literature findings in ambulatory internal medicine]
Vu F., Ceppi M., Fasel E., Dory E., Amstutz V., Monney C., Nanchen D., Clair Willi C., Pasche O., Vauthey L. et al., 2013. Revue Médicale Suisse, 9 (370) pp. 186-192.
[Pmid][serval:BIB_F1A52DCF2860]
 
Resting heart rate and incident heart failure and cardiovascular mortality in older adults: role of inflammation and endothelial dysfunction: the PROSPER study.
Nanchen D., Stott D.J., Gussekloo J., Mooijaart S.P., Westendorp R.G., Jukema J.W., Macfarlane P.W., Cornuz J., Rodondi N., Buckley B.M. et al., 2013. European Journal of Heart Failure, 15 (5) pp. 581-588. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_47D41EEDF061]
 
Resting heart rate and the risk of heart failure in healthy adults: the rotterdam study.
Nanchen D., Leening M.J., Locatelli I., Cornuz J., Kors J.A., Heeringa J., Deckers J.W., Hofman A., Franco O.H., Stricker B.H. et al., 2013. Circulation. Heart Failure, 6 (3) pp. 403-410. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_99C96E669514]
2012
 
Impact of carotid plaque screening on smoking cessation and other cardiovascular risk factors: a randomized controlled trial.
Rodondi Nicolas, Collet Tinh-Hai, Nanchen David, Locatelli Isabella, Depairon Michèle, Aujesky Drahomir, Bovet Pascal, Cornuz Jacques, 2012/02. Archives of Internal Medicine, 172 (4) pp. 344-352. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0518CEF1C9FF]
 
Acquisitions thérapeutiques en médecine ambulatoire en 2011. [2011 findings from literature on general internal ambulatory medicine]
Collet T.H., Pasche O., Ceppi M., Nanchen D., Amstutz V., Gonthier A., Fasel E., El Olmi K., Bodenmann P., 2012. Revue Médicale Suisse, 8 (326) pp. 270-275. Peer-reviewed.
[Pmid][serval:BIB_B985E164C6D4]
Mortality associated with diabetes and cardiovascular disease in older women.
Nanchen D., Rodondi N., Cornuz J., Hillier T., Ensrud K.E., Cauley J.A., Bauer D.C., Study of Osteoporotic Fractures Research Group, 2012. Plos One, 7 (11) pp. e48818. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FB801CADCA1F]
 
Prevenire l'aumento di peso dopo avere smesso di fumare: nessuna soluzione miracolosa: revisione Cochrane per il medico di famiglia.
Nanchen David, Willi Carole, Peytremann Bridevaux Isabelle, Barazzoni Fabrizio (Trad.), Ghirlanda Alberto (Trad.), 2012. Tribuna medica ticinese, 77 (2) pp. 67-69.
[URN][serval:BIB_1220C1ECD907]
 
Should we perform carotid plaque screening to improve smoking cessation and other cardiovascular risk factors?: a randomised controlled trial.
Rodondi Nicolas, Collet Tinh-Hai, Nanchen David, Giraudon K., Depairon Michèle, Bovet Pascal, Cornuz Jacques, 2012. pp. 10S dans 79e Assemblée annuelle de la Société suisse de médecine interne générale, Lausanne, Suisse, 11-13 mai 2011, Swiss Medical Forum.
[serval:BIB_B89201256672]
Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts.
Gencer B., Collet T.H., Virgini V., Bauer D.C., Gussekloo J., Cappola A.R., Nanchen D., den Elzen W.P., Balmer P., Luben R.N. et al., 2012. Circulation, 126 (9) pp. 1040-1049. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_57B186D69971]
 
Subclinical Thyroid Dysfunction and the Risk of Heart Failure in Older Persons at High Cardiovascular Risk.
Nanchen D., Gussekloo J., Westendorp R.G., Stott D.J., Jukema J.W., Trompet S., Ford I., Welsh P., Sattar N., Macfarlane P.W. et al., 2012. Journal of Clinical Endocrinology and Metabolism, 97 (3) pp. 852-861. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DA4370DD17A5]
Tasso di omocisteina e diminuzione del rischio cardiovascolare: nessun effetto delle vitamine B: revisione Cochrane per il medico di famiglia.
Nanchen David, Rodondi Nicolas, Peytremann Bridevaux Isabelle, Barazzoni Fabrizio (Trad.), Pelli Stefania (Trad.), 2012. Tribuna medica ticinese, 77 (Luglio-agosto) pp. 283-285.
[URN][serval:BIB_72BE97EE23D5]
2011
 
Public health impact of statin prescribing strategies based on JUPITER.
Nanchen D., Pletcher M.J., Cornuz J., Marques-Vidal P.M., Paccaud F., Waeber G., Vollenweider P., Rodondi N., 2011/02. Preventive medicine, 52 (2) pp. 159-163. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EE2A9740026B]
 
Gewisse Patienten profitieren von einem Selfmanagement der oralen Antikoagulation.
Nanchen David, Mazzolai Lucia, Peytremann-Bridevaux Isabelle, 2011. Praxis, 100 (16) pp. 983-984.
[DOI][Pmid][serval:BIB_B9994EC179B5]
 
Statins for cardiovascular prevention according to different strategies: a cost analysis.
Marques-Vidal P.M., Ito Marcia K., Nanchen D., Rodondi N., Paccaud F., Waeber G., Vollenweider P., 2011. pp. 9S-10S dans AGLA Update Meeting 2011, Kardiovaskuläre Medizin = Médecine Cardiovasculaire.
[serval:BIB_47DEFDB2BFE9]
 
Statins for cardiovascular prevention according to different strategies: a cost analysis.
Ito M.K., Nanchen D., Rodondi N., Paccaud F., Waeber G., Vollenweider P., Marques-Vidal P., 2011. American Journal of Cardiovascular Drugs, 11 (1) pp. 33-44. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_58200D377846]
2010
 
Alcohol drinking, the metabolic syndrome and diabetes in a population with high mean alcohol consumption.
Clerc O., Nanchen D., Cornuz J., Marques-Vidal P., Gmel G., Daeppen J.B., Paccaud F., Mooser V., Waeber G., Vollenweider P. et al., 2010/11. Diabetic medicine, 27 (11) pp. 1241-1249. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B5079276064E]
 
Prescription de statines en prévention primaire: quel score de risque cardiovasculaire faut-il utiliser en Suisse? [Statin prescription in primary prevention: which cardiovascular risk score should be used in Switzerland?]
Nanchen D., Chiolero A., Marques-Vidal P.M., Cornuz J., Waeber G., Vollenweider P., Rodondi N., 2010/03/10. Revue medicale suisse, 6 (239) pp. 488-490,492-493. Peer-reviewed.
[Pmid][serval:BIB_ABDEE3E22E0F]
Réponse des auteurs "Comment présenter à un patient l'efficacité d'un traitement ?"
Nanchen David, Bodenmann Patrick, Cornuz Jacques, 2010/03. Revue médicale suisse, 7 (238) pp. 474-475. Peer-reviewed.
[URN][DOI][serval:BIB_17501C737DE8]
 
L'autogestion de l'anticoagulation orale: un avantage pour certains patients: revue Cochrane pour le praticien
Nanchen David, Mazzolai Lucia, Peytremann Bridevaux Isabelle, 2010. Revue médicale suisse, 6 (273) p. 2320.
[serval:BIB_5238914EFC6D]
 
Lu pour vous: Prévention cardiovasculaire: efficacité des statines chez les plus de 70 ans
Nanchen David, 2010. Revue médicale suisse, 6 (253) p. 1267.
[serval:BIB_FAA36560AF10]
 
Nouveautés en médecine interne générale ambulatoire (2) [General internal medicine: review of year 2009 from the ambulatory perspective (2)]
Bodenmann P., Pasche O., de Bosset V., Cheseaux M., Nanchen D., Regazzoni L., Cornuz J., 2010. Revue Médicale Suisse, 6 (234) pp. 239-243.
[Pmid][serval:BIB_987A942FDD6E]
 
Public health impact of statin prescribing strategies based on jupiter
Nanchen David, Pletcher Mark, Waeber Gerard, Vollenweider Peter, Mooser Vincent, Marques-Vidal Pedro-Manuel, Paccaud Fred, Rodondi Nicolas, Cornuz Jacques, 2010. pp. 370-371 dans 33rd Annual Meeting of the Society of General Internal Medicine, Minneapolis (MN), United States, 18 April-1 May 2010, Journal of General Internal Medicine. Peer-reviewed.
[WoS][serval:BIB_481C214AD5FD]
 
Statins for cardiovascular prevention according to different strategies: a cost analysis
Ito M. Keiko , Marques-Vidal Pedro Manuel, Nanchen David, Rodondi Nicolas, Paccaud Fred, Waeber Gérard, Vollenweider Peter, 2010. pp. S33 dans European Journal of Cardiovascular Prevention and Rehabilitation. Peer-reviewed.
[DOI][serval:BIB_4D204B0A33EC]
Taux d'homocystéine et diminution du risque cardiovasculaire: pas d'effet des vitamines B: revue Cochrane pour le praticien
Nanchen David, Rodondi Nicolas, Peytremann Bridevaux Isabelle, 2010. Revue médicale suisse, 6 (238) p. 472.
[URN][serval:BIB_DE341D687E77]
2009
Cardiovascular risk estimation and eligibility for statins in primary prevention comparing different strategies.
Nanchen D., Chiolero A., Cornuz J., Marques-Vidal P.M., Firmann M., Mooser V., Paccaud F., Waeber G., Vollenweider P., Rodondi N., 2009/04/15. The American journal of cardiology, 103 (8) pp. 1089-1095. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B58E0BF60A4C]
Combining bone resorption markers and heel quantitative ultrasound to discriminate between fracture cases and controls.
Nanchen D., Cornuz J., Ruffieux C., Riesen W., Burckhardt P., Krieg M.A., 2009. Osteoporosis International, 20 (10) pp. 1695-1703. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BF3A9C15FC05]
 
Could moderate alcohol consumption help prevent the metabolic syndrome and diabetes mellitus ?
Clerc Olivier, Nanchen David, Marques-Vidal Pedro Manuel, Gmel Gerhard, Daeppen Jean-Bernard, Paccaud Fred, Mooser Vincent, Cornuz Jacques, Waeber Gérard, Vollenweider Peter et al., 2009. pp. 32S-33S dans 15th Wonca Europe Conference, Basel (Switzerland), 16­-19 September 2009, Swiss Medical Weekly. Peer-reviewed.
[serval:BIB_2AAD63C4CB10]
 
Mortality associated with diabetes mellitus in comparison with history of cardiovascular disease in older women.
Nanchen David, Rodondi Nicolas, Cornuz Jacques, Hillier T., Ensrud K.E., Cauley J.A., Bauer Douglas C., 2009. pp. S125 dans 32nd Annual Meeting of the Society of General Internal Medicine, Miami Beach, Florida, May 13-16, 2009, Journal of General Internal Medicine. Peer-reviewed.
[serval:BIB_881E4DA0E2BD]
 
Mortality associated with diabetes mellitus in comparison with history of cardiovascular disease in older women.
Nanchen D., Rodondi N., Cornuz J., Hillier T., Ensrud K.E., Cauley J.A., Bauer Douglas C., 2009. pp. 19S dans 15th Wonca Europe Conference, Basel (Switzerland), 16­-19 September 2009, Swiss Medical Weekly. Peer-reviewed.
[serval:BIB_FEF0D7771A9A]
Prévenir la prise de poids à l'arrêt du tabac: pas de solution miracle: revue Cochrane pour le praticien. [Preventing weight gain in smoking cessation: there is no miracle solution]
Nanchen David, Willi Carole, Peytremann Bridevaux Isabelle, Burnand Bernard, Rège Walther Myriam, 2009. Revue médicale suisse, 5 (212) p. 1577.
[URN][Pmid][serval:BIB_19681AB3F82D]
2008
 
Cardiovascular risk estimation and eligibility for statin therapy using different scoring systems in Europe: a population-based study in Switzerland
Nanchen David, Chiolero Arnaud, Cornuz Jacques, Firmann Mathieu, Marques-Vidal Pedro Manuel, Mooser Vincent, Paccaud Fred, Waeber Gérard, Vollenweider Peter, Rodondi Nicolas, 2008. p. 261 dans 31st Annual Meeting of the Society of General Internal Medicine, Pittsburgh, Pennsylvania, USA, April 9-12, 2008, Journal of General Internal Medicine. Peer-reviewed.
[DOI][serval:BIB_08227587FBBE]
 
Carotid plaque screening as a motivational tool for healthy behavior
Nanchen David, Cornuz Jacques, Bovet Pascal, Rodondi Nicolas, 2008. American Heart Journal, 155 (4) pp. e37. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A1A1C05162D7]
 
Eligibility for statin therapy in primary prevention: discrepancies using different guidelines in a population-based study in Switzerland
Nanchen David, Chiolero Arnaud, Cornuz Jacques, Firmann Mathieu, Marques-Vidal Pedro Manuel, Mooser Vincent, Paccaud Fred, Waeber Gérard, Vollenweider Peter, Rodondi Nicolas, 2008. pp. 12S dans 76e Assemblée annuelle de la Société suisse de médecine interne (SGIM/SSMI), Swiss Medical Forum = Forum Médical Suisse.
[serval:BIB_194DD569B325]
 
Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality
Ochs N., Auer R., Bauer D. C., Nanchen D., Gussekloo J., Cornuz J., Rodondi N., 2008. Annals of Internal Medicine, 148 (11) pp. 832-845. Peer-reviewed.
[WoS][Pmid][serval:BIB_E5EC65C5B18B]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University